LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2047-9158
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease ; volume:11 ; number:1 ; day:31 ; month:1 ; year:2022 ; pages:1-14 ; date:12.2022
Translational neurodegeneration ; 11, Heft 1 (31.1.2022), 1-14, 12.2022
- Urheber
-
Pang, Shirley Yin-Yu
Lo, Rachel Cheuk Nam
Ho, Philip Wing-Lok
Liu, Hui-Fang
Chang, Eunice Eun Seo
Leung, Chi-Ting
Malki, Yasine
Choi, Zoe Yuen-Kiu
Wong, Wing Yan
Kung, Michelle Hiu-Wai
Ramsden, David Boyer
Ho, Shu-Leong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40035-022-00281-6
- URN
-
urn:nbn:de:101:1-2022050820433892646168
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pang, Shirley Yin-Yu
- Lo, Rachel Cheuk Nam
- Ho, Philip Wing-Lok
- Liu, Hui-Fang
- Chang, Eunice Eun Seo
- Leung, Chi-Ting
- Malki, Yasine
- Choi, Zoe Yuen-Kiu
- Wong, Wing Yan
- Kung, Michelle Hiu-Wai
- Ramsden, David Boyer
- Ho, Shu-Leong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Correction: Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
Dual-Task Performance in GBA Parkinson’s Disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
GBA mutations and Parkinson's disease in Brazil
Dual-Task Performance in GBA Parkinson's Disease
GBA-associated Parkinson: does personalized medicine work in Parkinson's disease?
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
LRRK2 in Parkinson's disease and dementia with Lewy bodies
Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Correction: Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
Dual-Task Performance in GBA Parkinson’s Disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
GBA mutations and Parkinson's disease in Brazil
Dual-Task Performance in GBA Parkinson's Disease
GBA-associated Parkinson: does personalized medicine work in Parkinson's disease?
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
LRRK2 in Parkinson's disease and dementia with Lewy bodies
Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Correction: Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
Dual-Task Performance in GBA Parkinson’s Disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
GBA mutations and Parkinson's disease in Brazil
Dual-Task Performance in GBA Parkinson's Disease
GBA-associated Parkinson: does personalized medicine work in Parkinson's disease?
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition